ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TILS Tiziana Life Sciences Plc

58.50
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tiziana Life Sciences Plc LSE:TILS London Ordinary Share GB00BKWNZY55 ORD 3P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 58.50 45.00 60.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Tiziana Life Sciences Share Discussion Threads

Showing 101 to 123 of 17925 messages
Chat Pages: Latest  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
09/9/2014
01:24
Sign me up! LOL!
stav5001
08/9/2014
10:42
yes meets every 10p rise
rovi67
02/9/2014
17:25
Do we have a fan club here?
stav5001
28/8/2014
19:26
Showing as 56 on lse.
impala391
28/8/2014
10:27
Showing as zero share price on iii?
stav5001
15/8/2014
18:47
Herds gone then!
impala391
08/8/2014
17:35
They only drop it because of the options IMO. Lol
Still he whoever he or she was got a nice!

impala391
04/8/2014
17:06
andrbea 25 Jul'14 - 09:12 - 92 of 102 0 1

15% today
really illiquid this one....
what would it do if the herd were to arrive?

Well now we know lol.😎

impala391
03/8/2014
18:11
Interesting read, for anyone who wants to know what TILS is upto.

Hxxp://cardiffstudentmedia.co.uk/gairrhydd/science/cardiff-university-working-on- novel-treatments-for-breast-cancer-spread/

impala391
27/7/2014
00:22
What a graph!

If only RGT could have looked like that, we have been diluted to Kingdom come, but it is good to see some value and hope here at last for the longterm holders.

Not much but better than nothing.

stav5001
26/7/2014
17:01
Prof. Di Fiore has an alliance with TILS
The former has a new article (co-author/mentor perhaps) in the literature:

hxxp://jcb.rupress.org/content/206/2/307.abstract

andrbea
25/7/2014
13:35
lol! ... another 15 quid ish to go and i'll be in profit :))
stew99
25/7/2014
11:55
i suppose the up side is, these are free for us RGT holders...or are they :)
mdavies238
25/7/2014
11:40
It is expected for rgt holders to be sceptical, but ! ? # What a whoosh
rovi67
25/7/2014
11:07
jump on the same band wagon RGT had 10 years ago... and still waiting
mdavies238
25/7/2014
10:31
What would it do if a positive bit of news were to be released.🙀
impala391
25/7/2014
09:12
15% today
really illiquid this one....
what would it do if the herd were to arrive?

andrbea
24/7/2014
20:30
Once bitten, twice shy....

I have a few and I am glad to see a few more posts here.

stav5001
24/7/2014
16:45
welcome aboard Indyanna
andrbea
24/7/2014
15:41
As a former RGT/ADI holder wasn't sure about this but decided to average down and topped up at 42p. Enjoying the ride and only 89 posts since April.
Very low volume, imagine what could happen if the rampers/herd arrive.
That's my post for the year. Going back to watch mode

indyanna
24/7/2014
15:27
tils 14%
getting the recognition it deserves (for a lowly mkt cap 5.4m)

remeber the credentials of our advisor:

"... who has linked his name to the discovery of Aventis, the world's most widely used anticancer drug, sold 7 billion dollars in 2013 alone".

andrbea
24/7/2014
14:09
which is already the encouraging developments. " The project concerns the biotechnology drugs for treatment and diagnosis cancer, particularly breast cancer. Initially, the company has funded a search of a trio of scientists from the University of Cardiff, the Italian Andrea Brancale and the British Richard Clarkson and Andrew Westwell, which continues today with positive results. Following the radius of the research has expanded, always on the double track of the earliest possible diagnosis and treatment for overt tumors in advanced stage. In May, he was named president of the group dell'advisoryboard Napoleone Ferrara, a professor and researcher at the Cancer Center of the University of California San Diego who has linked his name to the discovery of Aventis, the world's most widely used anticancer drug, sold 7 billion dollars in 2013 alone. So, a few days ago, Tiziana Life has entered into an agreement with the team of Pier Paolo Di Fiore, professor of medicine at the University of Milan and associate at the European Institute of Oncology was founded by Umberto Veronesi, who is carrying out a research on stem cells of breast cancers. "A tumor can be compared - explains the Flower - a beehive composed in large part of worker bees, that being infertile can not repopulate. The growth function is the prerogative of the queen bees, the only ones able to proliferate. Stem cells are indeed the queens of the tumor. The number of stem cell-queens present in a tumor predicts how quickly it will grow and how aggression. Stem cells are the target selective short to reach to strike at the heart of the tumor in an attempt to eradicate it. " The search for Di Fiore is oriented both to the front of the diagnostic to that of the therapy. First, it is more advanced, "We have found new" markers "specific that allow us to make a faster and more accurate prognosis. Now we are aiming to get to the clinic to bring the results of our research from laboratory tests to medical practice. Just at this stage is crucial to succeed a company, in this case the fact Tiziana, who then will decide and fund the equally important part of the commercialization and marketing. "

taken from

hxxp://www.repubblica.it/economia/affari-e-finanza/2014/06/30/news/tiziana_risposta_italiana_alla_bolla_speculativa_del_comparto_biotech-90325266/

andrbea
24/7/2014
11:19
our advisor has a post in Califonia too

The program closes with the presentation of the Rell Sunn Award. The 2014 honoree is Napoleone Ferrara, M.D., a world-renowned molecular biologist, who is credited with helping decipher how tumors grow. Ferrara currently serves as senior deputy director for basic science at UC San Diego Moores Cancer Center.

hxxp://www.midasletter.com/2014/06/westhaven-ventures-forges-ahead-british-columbia/

andrbea
Chat Pages: Latest  9  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock